A
Attralus Therapeutics
0 followers
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.
Org chart
Mark Timney
CEO
Collapse
Spencer Guthrie
Co-Founder & COO
Glen Firestone
Chief Business Officer
Gregory Bell
Chief Medical Officer
Jonathan Wall
Co-Founder & Interim Chief Scientific Officer
James Testa
VP, Finance
Christine Huh
Head, Human Resources
Mike Klein
Senior Vice President, Head of CMC
Dave Conroy
Head of Program Management
Matthew Meldorf
Senior Vice President Clinical Development
Board & advisors
Richard Gaster
Board Member
Rahul Kakkar
Board Member
Corey Goodman
Board Member
Nancy Miller-Rich
Board Member
Jake Bauer
Board Member
Alexander Denner
Board Member
Jaume Pons
Scientific Advisor
Jeff Kelly
Scientific Advisor
Morie Gertz
Scientific Advisor
Mathew Maurer
Scientific Advisor